Atlas Trials

CatalYm GmbH

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch CatalYm GmbH

RecordFirmDate
Visugromab in Cachexia International Trial (NCT07112196)CatalYm GmbH2026-04-16
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure (NCT07219459)CatalYm GmbH2026-03-19
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC (NCT07246863)CatalYm GmbH2025-10-07
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC (NCT07098988)CatalYm GmbH2025-08-01
Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer (NCT06059547)CatalYm GmbH2023-09-06
First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER) (NCT04725474)CatalYm GmbH2020-12-09

Track CatalYm GmbH automatically

Every clearance here is in the API, with alerts when new ones post.